Use of levamisole in cancer patients.
D006801:Humans; D007109:Immunity / Q000187:drug effects; D007978:Levamisole / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008214:Lymphocytes / Q000187:drug effects; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010586:Phagocytes / Q000187:drug effects
D007978:Levamisole